Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029
NCT00563810
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
MYO-029
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer